What amount of copper is lost daily in the output of an enteric (enterocutaneous) fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Copper Loss Through Fistula Output

Patients with enterocutaneous fistulas lose approximately 0.1-0.2 mg of copper per day through fistula output, requiring supplementation of 0.4-0.5 mg/day of copper in parenteral nutrition to maintain copper balance.

Quantifying Copper Losses

The most direct evidence comes from a 1981 metabolic balance study that specifically measured copper losses in patients with gastrointestinal fistulas 1. This study demonstrated that:

  • Patients with high-output stomas or fistulas have increased gastrointestinal copper losses compared to those with normal GI function
  • Copper requirements increase from 0.3 mg/day (normal GI losses) to 0.4-0.5 mg/day in patients with diarrhea or increased fluid losses through fistulas 1
  • This represents an additional 0.1-0.2 mg/day loss attributable to the fistula output itself

Clinical Context and Mechanism

The ESPEN 2022 micronutrient guideline confirms that increased gastrointestinal losses of copper are observed in patients with enterocutaneous fistulas 2. This occurs because:

  • Most absorbed copper is normally lost via biliary excretion into the GI tract 2
  • When fistula output bypasses normal reabsorption mechanisms, this copper is lost externally
  • The magnitude of loss correlates with the volume and location of fistula output

Practical Supplementation Strategy

For patients on parenteral nutrition with enterocutaneous fistulas:

  • Standard PN copper provision of 0.5-1.2 mg/day may be insufficient 2
  • Target 0.4-0.5 mg/day minimum based on metabolic balance data 1
  • Monitor serum copper levels: Values <12 μmol/L with CRP >20 mg/L suggest deficiency; values <8 μmol/L indicate need for repletion 2
  • Treatment of established deficiency requires 4-8 mg/day 2

Important Caveats

  • Plasma copper does not reliably reflect copper balance and cannot be used as the sole guide for supplementation 1
  • Urinary copper excretion is approximately twice normal in patients receiving PN 1
  • Copper infused in excess of requirements is retained, not excreted 1, so avoid over-supplementation in patients with cholestasis
  • Patients with abnormal liver excretory function have decreased GI copper losses and may require less supplementation 1

Monitoring Approach

  • Check serum copper at baseline and every 6-12 months during long-term PN 2
  • More frequent monitoring if cholestasis develops 2
  • Watch for clinical signs of deficiency: microcytic anemia, neutropenia, delayed wound healing, hair depigmentation 2
  • Adjust supplementation based on fistula output volume and liver function

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.